ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Resveratrol attenuates atherosclerotic endothelial injury through the Pin1/Notch1 pathway

Yu, Guo-hui; Fang, Yong*y
Toxicology and Applied Pharmacology2022-7-1DOI: 10.1016/j.taap.2022.116047
7被引7阅读
引用收藏
分享

摘要

The present study investigates whether resveratrol could modulate the endothelial dysfunction of atherosclerosis via the Pin1/Notch1 signaling pathway. To assess the vascular endothelial cell (VECs) injury in mice, the levels of serum soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), soluble E-selectin (sE-selectin), soluble thrombomodulin (sTM), and von Willebrand factor (vWF) were measured. Expressions of Pin1 and Notch1 intracellular domain (NICD1), both mRNA and protein, were also measured. Human umbilical vein endothelial cells (HUVECs) treated with 100 mu g/mL oxidized low-density lipoprotein (ox-LDL) were incubated with resveratrol at doses from 10 mu M to 40 mu M. Cell function was evaluated by measuring apoptosis, cell viability, lipid accumulation, and adherent human myeloid leukemia mononuclear (THP-1) cells. Resveratrol intervention in AS mice decreased the expression of serum sVCAM-1, sICAM-1, sE-selectin, sTM, and vWF and dose-dependently down-regulated Pin1 and NICD1 mRNA and protein expression in endothelial cells. Resveratrol intervention reversed ox-LDL-induced cell dysfunction by increasing viability and decreasing apoptosis, lipid accumulation, and the adhesion of THP-1 cells. These beneficial effects were reversed by the overexpression of Pin1. Resveratrol regulates endothelial cell injury of atherosclerosis by inhibiting the Pin1/Notch1 signaling pathway, suggesting novel therapeutic targets for atherosclerosis treatment.

学科与关键词

关键词
ResveratrolEndothelial cell injuryPin1Notch1Atherosclerosis
相关
加载中…
  • Atherosclerosis-associated endothelial dysfunction is promoted by miR-199a-5p/SIRT1 axis regulated by circHIF1?
    Qiao, Shan; Wang, Xing; Li, Haiyun; Zhang, Canling; Wang, Aihua; Zhang, Shanchao*Nutrition, Metabolism and Cardiovascular Diseases, 2023, 33(8): 1619-1631.被引 1
  • Poly(ADP-ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications
    Xu Suowen*; Bai Peter; Little Peter J; Liu PeiqingMedicinal Research Reviews, 2014, 34(3): 644-675.被引 8
  • Resveratrol Inhibits Abdominal Aortic Aneurysm Progression by Reducing Extracellular Matrix Degradation, Apoptosis, Autophagy, and Inflammation of Vascular Smooth Muscle Cells via Upregulation of HMOX1
    Qu, Yunfei; Zhang, Ning; Zhao, Yu*Journal of Endovascular Therapy, 2023.
查看全部 →

发表信息

论文状态
公开发表
期刊
Toxicology and Applied Pharmacology
发表日期
2022-07-01
卷期
第 446 卷
页码
116047
DOI
10.1016/j.taap.2022.116047
语言
ENGLISH
期刊等级
3区
成果收录
SCIE

作者

  • Y

    Yu, Guo-hui (第一作者)

    wuhan univ sci & technol

  • F

    Fang, Yong (通讯)

    wuhan univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417